A recent study found that the respiratory and non-respiratory symptom burden in patients with COPD is high when compared with ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

These symptoms could be early signs of COPD (Chronic Obstructive Pulmonary Disease), a progressive lung disease that is one of the leading causes of illness and death worldwide. COPD is caused by ...

Distinct patterns of symptom severity among patients with COPD sheds light on the heterogeneous nature of the patients’ ...

Could both indoor and outdoor air pollution significantly worsen respiratory health in patients with COPD? Find out.

Complex, nationwide analysis included both social and environmental factors and could inform local and national policy.

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

For those with pre-existing conditions like asthma or COPD, particulate matter can trigger exacerbations and accelerate ...

Long COVID development may be influenced by severity of the initial COVID-19 illness and preexisting respiratory conditions, including COPD and OSA.

Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...